123 related articles for article (PubMed ID: 7615048)
1. Evidence for involvement of activated CD8+/HLA-DR+ cells in the pathogenesis of neutropenia in patients with B-cell chronic lymphocytic leukaemia.
Katrinakis G; Kyriakou D; Alexandrakis M; Sakellariou D; Foudoulakis A; Eliopoulos GD
Eur J Haematol; 1995 Jul; 55(1):33-41. PubMed ID: 7615048
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of normal human hematopoiesis by marrow CD3+, CD8+, HLA-DR+, HNK1+ lymphocytes.
Vinci G; Vernant JP; Nakazawa M; Zohair M; Katz A; Henri A; Rochant H; Breton-Gorius J; Vainchenker W
Blood; 1988 Nov; 72(5):1616-21. PubMed ID: 2972326
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia.
Manukyan G; Turcsanyi P; Mikulkova Z; Gabcova G; Urbanova R; Gajdos P; Smotkova Kraiczova V; Zehnalova S; Papajik T; Kriegova E
Leuk Res; 2018 Sep; 72():113-119. PubMed ID: 30149317
[TBL] [Abstract][Full Text] [Related]
4. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
Scrivener S; Goddard RV; Kaminski ER; Prentice AG
Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
[TBL] [Abstract][Full Text] [Related]
5. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.
Rea IM; McNerlan SE; Alexander HD
Exp Gerontol; 1999 Jan; 34(1):79-93. PubMed ID: 10197730
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
[TBL] [Abstract][Full Text] [Related]
7. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
8. Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL).
Rossmann ED; Lewin N; Jeddi-Tehrani M; Osterborg A; Mellstedt H
Eur J Haematol; 2002 May; 68(5):299-306. PubMed ID: 12144536
[TBL] [Abstract][Full Text] [Related]
9. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia.
Rezvany MR; Jeddi-Tehrani M; Rabbani H; Lewin N; Avila-Cariño J; Osterborg A; Wigzell H; Mellstedt H
Br J Haematol; 2000 Nov; 111(2):608-17. PubMed ID: 11122109
[TBL] [Abstract][Full Text] [Related]
10. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
11. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
Gessl A; Waldhäusl W
Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
[TBL] [Abstract][Full Text] [Related]
12. CD8+HLA-DR+ T cells are increased in patients with severe aplastic anemia.
Xing L; Liu C; Fu R; Wang H; Wang J; Liu X; Feng L; Li L; Liu H; Wang H; Zhang T; Shao Z
Mol Med Rep; 2014 Sep; 10(3):1252-8. PubMed ID: 24969051
[TBL] [Abstract][Full Text] [Related]
13. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
[TBL] [Abstract][Full Text] [Related]
14. Defective natural killer cell activity in B-cell chronic lymphocytic leukaemia is associated with impaired release of natural killer cytotoxic factor(s) but not of tumour necrosis factor-alpha.
Katrinakis G; Kyriakou D; Papadaki H; Kalokyri I; Markidou F; Eliopoulos GD
Acta Haematol; 1996; 96(1):16-23. PubMed ID: 8677756
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
[TBL] [Abstract][Full Text] [Related]
16. In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2003 Jan; 131(1):82-9. PubMed ID: 12519390
[TBL] [Abstract][Full Text] [Related]
17. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease.
Tötterman TH; Carlsson M; Simonsson B; Bengtsson M; Nilsson K
Blood; 1989 Aug; 74(2):786-92. PubMed ID: 2787679
[TBL] [Abstract][Full Text] [Related]
18. A low blood lymphocyte count is associated with an expansion of activated cytotoxic lymphocytes in patients with B-cell chronic lymphocytic leukaemia.
Martín AP; Martín ER; García-Suárez J; Arriagada FC; del Puerto Hernandez-Fuentes M; Vilaplana JC; Alvarez-Mon Soto M
Eur J Haematol; 1997 Aug; 59(2):89-99. PubMed ID: 9293856
[TBL] [Abstract][Full Text] [Related]
19. Adhesion molecules, endogenous granulocyte colony-stimulating factor levels and replating capacity of progenitors in autoimmune neutropenia of childhood.
Perdikogianni Ch; Dimitriou H; Stiakaki E; Markaki EA; Kalmanti M
Acta Paediatr; 2003 Nov; 92(11):1277-83. PubMed ID: 14696847
[TBL] [Abstract][Full Text] [Related]
20. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
